首页> 外文期刊>Nurse Media: Journal of Nursing >A Case of Acute Myocardial Infarction during Chemotherapy of Advanced Rectal Cancer
【24h】

A Case of Acute Myocardial Infarction during Chemotherapy of Advanced Rectal Cancer

机译:晚期直肠癌化疗期间急性心肌梗死1例

获取原文
           

摘要

Background : Cetuximab, irinotecan, levoforinate, and 5-FU (FOLFIRI) are medicines commonly administered to advanced colorectal cancer patients through chemotherapy. Although this regimen is standardized for recurrent metastatic colorectal cancer, the emerging of myocardial infarction is rare. Purpose : The purpose of this study was to consider the development of myocardial infarction during the chemotherapy of colorectal cancer. Method s : A retrospective case study was conducted to one patient. An 80-year-old man who developed acute myocardial infarction was in chemotherapy with cetuximab + FOLFIRI with multiple lung metastases after rectal cancer surgery. Data were collected from the patient’s medical and nursing records as well as the physiological function test results. Result s : Three days after the 38th administration, the patient visited an emergency outpatient mainly with complaints of dyspnea and back pain. Electrocardiogram showed that the lower wall infarction was suspected. The patient was transferred to a specialized cardiovascular hospital. Emergency coronary angiography was performed in the diagnosis of acute myocardial infarction, and percutaneous coronary intervention was performed. The patient was discharged on the 10 th of disease day. Conclusion : In this case, it was thought that cetuximab + FOLFIRI synergistically induced hyper thrombogenicity, coronary plaque erosion, and acute myocardial infarction. It may also be necessary for interventions such as monitoring the risks in daily living by the medical care providers and guidance on risk avoidance behaviors.
机译:背景:西妥昔单抗,伊立替康,左旋叶酸和5-FU(FOLFIRI)是通常通过化疗施用于晚期结直肠癌患者的药物。尽管该方案对于复发性转移性结直肠癌是标准化的,但心肌梗塞的发生却很少。目的:本研究的目的是考虑大肠癌化疗期间心肌梗塞的发展。方法:对一名患者进行回顾性病例研究。一名患有急性心肌梗塞的80岁男子在直肠癌手术后接受西妥昔单抗+ FOLFIRI化疗并伴有多处肺转移。数据是从患者的医疗和护理记录以及生理功能测试结果中收集的。结果:第38次给药后三天,患者就诊,主要表现为呼吸困难和腰痛。心电图显示怀疑是下壁梗塞。该患者被转到专门的心血管医院。对急性心肌梗死进行了紧急冠状动脉造影,并进行了经皮冠状动脉介入治疗。患者于疾病发生的第10天出院。结论:在这种情况下,认为西妥昔单抗+ FOLFIRI协同诱导了高血栓形成性,冠状动脉斑块侵蚀和急性心肌梗死。对于干预措施也可能是必要的,例如监视医疗服务提供者的日常生活风险以及对风险规避行为的指导。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号